NONPARTISAN · SOURCED FROM CONGRESS.GOV, OPENFEC, SENATE & HOUSE CLERKS · UPDATED REGULARLY
119th Congress · Senate bill · Last action Jun 8, 2026
BillsS. 4698Congress.gov ↗
S. 4698In Committee

A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.

Sponsor: Sen. Johnson, Ron [R-WI] (R-WI)1 cosponsorIntroduced Jun 8, 2026
In plain English

A plain-English summary will be generated the next time this page is viewed by an admin.

Where it is in the process

Introduced
Jun 8
Senate committee
Jun 8
3
Senate floor
-
4
House
-
5
Signed
-
What happens next: Sits in committee. Needs a markup or favorable report to advance to the Senate floor.

Sponsor

Cosponsors (1)

TS
All Republican.

Activity timeline

Jun 8
2d ago
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 8
2d ago
Introduced in Senate
Read the bill text
Official text via Congress.gov. Opens in a new tab.
Read full text →

Full action log

All 2 recorded actions since introduction · Source: Congress.gov
Jun 8
SENATERead twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 8
Introduced in Senate

All 1 cosponsor

0 Democrats · 1 Republican
Republicans (1)
Track this bill
Get an alert when it moves to the next stage or gets a vote.
Share
Embed this tracker on your site
Paste this HTML into your blog post or website to show a live tracker for this bill.
The embedded card updates automatically as the bill progresses. Preview →